2.93

0.34% -0.010

Fortress Biotech Inc (FBIO)

Overview News Price History Option Chain Financials Why FBIO Down? Discussions Forecast Stock Split

Fortress Biotech Inc stock is traded at $2.93, with a volume of 185.98K. It is down -0.34% in the last 24 hours and up +11.83% over the past month. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Previous Close:

$2.94

Open:

$2.95

24h Volume:

185.98K

Relative Volume:

0.26

Market Cap:

$90.94M

Revenue:

$80.97M

Net Income/Loss:

$-78.31M

P/E Ratio:

-0.2643

EPS:

-11.0849

Net Cash Flow:

$-129.56M

1W Performance:

+3.53%

1M Performance:

+11.83%

6M Performance:

+49.49%

1Y Performance:

+47.24%

1-Day Range:

$2.90

$3.00

1-Week Range:

$2.775

$3.00

52-Week Range:

$1.325

$4.20

Fortress Biotech Inc Stock (FBIO) Company Profile

Name

Fortress Biotech Inc

Sector

Healthcare (1123)

Industry

Biotechnology (627)

Phone

781-652-4500

Address

1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY

Employee

101

Twitter

@fortressbio

Next Earnings Date

2024-11-12

Latest SEC Filings

FBIO's Discussions on Twitter

Compare FBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FBIO Fortress Biotech Inc	2.93	91.25M	80.97M	-78.31M	-129.56M	-11.08
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-15-24	Resumed	ROTH MKM	Buy
Aug-04-22	Initiated	Ladenburg Thalmann	Buy
Oct-02-20	Initiated	The Benchmark Company	Buy
Dec-18-19	Initiated	B. Riley FBR	Buy
Feb-28-18	Initiated	B. Riley FBR, Inc.	Buy
Jul-11-17	Initiated	Rodman & Renshaw	Buy
Mar-22-17	Initiated	JMP Securities	Mkt Outperform
Oct-03-16	Initiated	ROTH Capital	Buy

View All

Fortress Biotech Inc Stock (FBIO) Latest News

Dec 10, 2025

Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology - GlobeNewswire

Dec 10, 2025

Dec 09, 2025

(FBIOP) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com

Dec 09, 2025

Dec 07, 2025

Published on: 2025-12-08 06:59:10 - BỘ NỘI VỤ

Dec 07, 2025

Dec 06, 2025

FBIOP | Fortress Biotech, Inc. 9.375% Stock Data, Price & News - Quiver Quantitative

Dec 06, 2025

Fortress Biotech (NASDAQ:FBIO) Share Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat

Dec 06, 2025

Fortress Biotech (NASDAQ:FBIO) Share Price Passes Above 200 Day Moving Average – Time to Sell? - Defense World

Dec 06, 2025

Dec 05, 2025

Avenue Therapeutics (NASDAQ: ATXI) 2025 proxy on director elections, KPMG audit and Fortress control - Stock Titan

Dec 05, 2025

Is Fortress Biotech Inc.(CNB0) stock undervalued historicallyWeekly Trading Summary & Pattern Based Trade Signal System - Newser

Dec 05, 2025

Dec 04, 2025